Reshaping Biotechnology’s Financing Relay Race
Biotech’s current funding crisis is unlike any previous funding challenge the sector has faced. In the past, funding droughts were largely driven by investor sentiment toward the biotech industry. When investors were bullish about the sector’s prospects — for instance, […]
Read More